The Application of Nanogels as Efficient Drug Delivery Platforms for Dermal/Transdermal Delivery

The delivery of active molecules via the skin seems to be an efficient technology, given the various disadvantages of oral drug administration. Skin, which is the largest human organ of the body, has the important role of acting as a barrier for pathogens and other molecules including drugs; in fact, it serves as a primary defense system blocking any particle from entering the body. Therefore, to overcome the skin barriers and poor skin permeability, researchers implement novel carriers which can effectively carry out transdermal delivery of the molecules. Another significant issue which medical society tries to solve is the effective dermal delivery of molecules especially for topical wound delivery. The application of nanogels is only one of the available approaches offering promising results for both dermal and transdermal administration routes. Nanogels are polymer-based networks in nanoscale dimensions which have been explored as potent carriers of poorly soluble drugs, genes and vaccines. The nanogels present unique physicochemical properties, i.e., high surface area, biocompatibility, etc., and, importantly, can improve solubility. In this review, authors aimed to summarize the available applications of nanogels as possible vehicles for dermal and transdermal delivery of active pharmaceutical ingredients and discuss their future in the pharmaceutical manufacturing field.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:9

Enthalten in:

Gels (Basel, Switzerland) - 9(2023), 9 vom: 15. Sept.

Sprache:

Englisch

Beteiligte Personen:

Siafaka, Panoraia I [VerfasserIn]
Özcan Bülbül, Ece [VerfasserIn]
Okur, Mehmet Evren [VerfasserIn]
Karantas, Ioannis D [VerfasserIn]
Üstündağ Okur, Neslihan [VerfasserIn]

Links:

Volltext

Themen:

Cross-linking
Delivery
Dermal
Journal Article
Nanogels
Responsive
Review
Skin
Transdermal

Anmerkungen:

Date Revised 03.10.2023

published: Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.3390/gels9090753

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM362507627